每经AI快讯，11月23日，禾元生物公告，公司于2025年11月21日召开第四届董事会第十一次会议，审议 通过了关于使用部分闲置募集资金进行现金管理的议案。公司拟使用不超过21亿元的暂时闲置募集资金 (含超募资金)购买安全性高、流动性好的保本型产品，包括但不限于协定性存款、结构性存款、定期存 款、通知存款、大额存单等。该额度自董事会审议通过之日起12个月内有效，在额度范围内可滚动使 用。公司明确，此次现金管理不会影响募集资金投资项目进度和公司正常生产经营，所得收益将优先用 于补足募投项目投资不足及补充流动资金，并按规定归还至募集资金专户。 ...

南财智讯11月23日电，禾元生物公告，公司于2025年11月21日召开第四届董事会第十一次会议，审议通 过了关于使用部分闲置募集资金进行现金管理的议案。公司拟使用不超过21.00亿元的暂时闲置募集资 金（含超募资金）购买安全性高、流动性好的保本型产品，包括但不限于协定性存款、结构性存款、定 期存款、通知存款、大额存单等。该额度自董事会审议通过之日起12个月内有效，在额度范围内可滚动 使用。公司明确，此次现金管理不会影响募集资金投资项目进度和公司正常生产经营，所得收益将优先 用于补足募投项目投资不足及补充流动资金，并按规定归还至募集资金专户。 ...

Core Viewpoint - The company plans to utilize idle raised funds for cash management, aiming to enhance the efficiency of fund usage and maximize shareholder returns while ensuring the safety of the funds [2][3][16]. Investment Overview - **Investment Purpose**: To improve the efficiency of raised funds and increase cash asset returns without affecting the normal implementation of investment projects [3]. - **Investment Amount**: The company intends to use up to RMB 600 million (including principal) of idle raised funds for cash management within 12 months from the board meeting approval [4][11]. - **Source of Funds**: The funds for cash management will come from temporarily idle raised funds from the company's initial public offering [5]. Investment Products - **Types of Investments**: The company will invest in high-security, liquid financial products, including but not limited to agreement deposits, structured deposits, time deposits, notice deposits, and large-denomination certificates of deposit [2][9]. - **Implementation Method**: After board approval, the management is authorized to make decisions regarding the selection of investment products and sign relevant legal documents [9]. Cash Management and Returns - **Return Distribution**: The income from cash management will be used primarily to cover any shortfall in investment amounts for projects and for the company's operational liquidity needs [9][16]. - **Recent Cash Management**: In the past 12 months, the company has also approved the use of up to RMB 650 million for cash management, indicating a consistent strategy to manage idle funds [10][11]. Risk Control Measures - **Risk Management**: The company will adhere to strict regulations and guidelines to ensure the safety of funds, including selecting reputable issuers and monitoring investment performance [15]. - **Supervision**: Independent directors and the audit committee will oversee the use of funds, with the option to hire professional auditors if necessary [15]. Impact on the Company - **Operational Impact**: The cash management initiative will not affect the company's daily operations or the progress of investment projects, aiming to enhance fund efficiency and shareholder returns [16][17]. - **Regulatory Compliance**: The cash management activities comply with relevant laws and regulations, ensuring no change in the intended use of raised funds [17][18].

登录新浪财经APP 搜索【信披】查看更多考评等级 ■ 公司本次发行的募集资金拟投资项目及使用计划如下： 单位：人民币 万元 苏州近岸蛋白质科技股份有限公司 关于使用暂时闲置募集资金进行现金管理的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 苏州近岸蛋白质科技股份有限公司（以下简称"公司"或"近岸蛋白"）于2025年10月13日召开第二届董事 会第十三次临时会议、第二届监事会第十次临时会议，审议通过了《关于使用暂时闲置募集资金进行现 金管理的议案》，同意公司在确保不影响募集资金投资项目建设和募集资金使用以及公司正常业务开展 的情况下,使用最高余额不超过人民币8亿元（包含本数）的暂时闲置募集资金购买安全性高、流动性 好、期限不超过12个月（含）的投资产品（包括但不限于协定性存款、结构性存款、定期存款、通知存 款、大额存单等）。在上述额度内,资金可以滚动使用,使用期限自董事会审议通过之日起12个月内有 效。 董事会授权公司管理层在授权额度和期限内行使现金管理投资决策权并签署相关合同文件，具体事项由 公司财务部负责组织实施 ...

Core Viewpoint - The company intends to utilize part of its temporarily idle raised funds for cash management and entrust part of its idle self-owned funds for wealth management, aiming to enhance fund utilization efficiency and increase returns without affecting the implementation of fundraising projects and the normal operation of the company [1][4][6]. Investment Overview - **Investment Purpose**: The company aims to improve fund utilization efficiency and increase returns while ensuring the safety of raised funds and normal operations [1]. - **Investment Amount and Duration**: The company plans to use up to RMB 100 million of temporarily idle raised funds for cash management and up to RMB 300 million of idle self-owned funds for wealth management, with a validity period of 12 months from the board's approval [2][7]. - **Source of Funds**: The funds are sourced from the proceeds of the company's initial public offering, which raised a net amount of RMB 467.1815 million after deducting issuance costs [2][3]. Investment Products - The company will invest in safe, liquid, and legally compliant financial products, including but not limited to structured deposits, time deposits, large certificates of deposit, and wealth management products [3][4][7]. Implementation and Disclosure - The board of directors authorizes the general manager to make investment decisions within the specified limits, and the finance department is responsible for implementation [4][6]. - The company will fulfill its information disclosure obligations in accordance with relevant regulations and will not change the purpose of the raised funds [4][6]. Impact on Daily Operations - The use of idle raised funds for cash management and self-owned funds for wealth management will not affect the normal development of the company's main business and will help improve fund utilization efficiency and increase returns for the company and its shareholders [4][5]. Approval Procedures - The company held several meetings to approve the proposal for using idle funds, including the board of directors, audit and risk committee, and independent directors, all of whom expressed agreement with the plan [6][8]. Sponsor's Verification Opinion - The sponsor believes that the company's plan to use idle funds for cash management and wealth management has been properly approved and will enhance fund utilization efficiency without changing the purpose of the raised funds [9].

Core Viewpoint - The company, Suzhou Ruikeda Connection Systems Co., Ltd., plans to utilize up to RMB 200 million of idle funds for cash management to enhance fund efficiency and returns for shareholders while ensuring normal business operations are not affected [1][2]. Summary by Sections Cash Management Plan - The company will use a maximum of RMB 200 million of idle self-owned funds for cash management, focusing on high-security and high-liquidity investment products such as time deposits and structured deposits [1]. - The cash management products will not be used for pledging or securities investment purposes [1]. Investment Duration and Authority - The funds can be used on a rolling basis within a 12-month period from the board's approval date [1]. - The board has authorized the management to make investment decisions and sign relevant contracts within the approved limits and timeframe [1]. Purpose and Benefits - The objective of this cash management is to improve the efficiency of self-owned funds and increase company returns while ensuring fund safety [1]. - The cash management will not impact the company's normal cash flow or main business operations, nor will it harm the interests of shareholders, especially minority shareholders [1][2]. Risk Management Measures - The company acknowledges potential market volatility and systemic risks but will implement strict procedures for cash management to ensure fund safety [2]. - Measures include adhering to regulations, establishing approval processes, and conducting timely analysis of investment products [2]. - The supervisory board has expressed clear agreement, confirming that the cash management will not affect normal operations or shareholder interests [2].

Core Viewpoint - Shanghai Titan Technology Co., Ltd. plans to continue using part of its idle raised funds for cash management, with a maximum amount of 400 million yuan, ensuring that it does not affect the construction and use of the raised funds investment projects [1][4]. Fundraising Situation - In 2022, Titan Technology issued 7,624,896 shares at a price of 131.61 yuan per share, raising a total of approximately 1.003 billion yuan, with a net amount of about 985 million yuan after deducting related issuance costs [2]. Previous Cash Management Situation - In August 2024, the company approved the use of up to 400 million yuan of idle raised funds for cash management, with funds stored in a special account for raised funds, allowing for immediate withdrawal [3]. Impact on the Company - The continued use of idle raised funds for cash management will not affect the normal operation of the investment projects and aims to generate more returns for the company and its shareholders [4]. Decision-Making Process and Opinions - The cash management matter has been approved by the board of directors and the supervisory board, and does not require submission to the shareholders' meeting. Independent directors and the supervisory board have expressed agreement, stating that the matter is legal and compliant, and aligns with the interests of the company and shareholders [5].

Core Viewpoint - The company Yifang Biotechnology (Shanghai) Co., Ltd. has approved the use of up to RMB 1 billion of temporarily idle raised funds for cash management to enhance fund utilization efficiency and increase returns for shareholders [1][2][4]. Fundraising Basic Situation - The company was approved to publicly issue 115 million shares at a price of RMB 18.12 per share, raising a total of RMB 2,083.8 million, with a net amount of approximately RMB 1,982.15 million after deducting related issuance costs [2]. Cash Management Details - The purpose of cash management is to improve the efficiency of raised fund usage while ensuring project construction and fund safety. The company plans to invest in high-security, liquid, and principal-protected financial products or deposit products, with a maximum investment period of 12 months [2]. - The decision is valid for 12 months from the date of board approval, and the funds can be used in a rolling manner [2]. Review Procedures and Risk Control - The company has established a robust approval and execution process for cash management, including measures such as using a special account, board authorization for operational decisions, and supervision by independent directors and internal audit departments [3]. - Despite choosing low-risk products, market fluctuations may still impact investments, and the company will ensure that funds are returned to the special account or rolled over upon maturity [3]. Impact on the Company and Sponsor Opinions - The cash management will not affect the company's daily cash flow, project construction progress, or main business development, while also improving fund utilization efficiency and overall performance [4]. - The sponsor institution has confirmed that the necessary decision-making procedures have been followed, and the action complies with relevant laws and regulations, with no objections raised regarding the matter [4].

Core Viewpoint - The company intends to utilize temporarily idle raised funds and its own funds for cash management to enhance fund efficiency and returns while ensuring that it does not affect the implementation of investment projects or the safety of funds [3][4][10]. Fundraising Overview - The company has raised a total of RMB 2,870,735,304.75 from the public offering of 79,411,765 shares at a price of RMB 36.15 per share, after deducting issuance costs of RMB 68,004,839.72 [3][4]. - The net amount of raised funds after costs is RMB 2,802,730,465.03 [3]. Investment Project Situation - The raised funds will be allocated to specific projects with a total investment of RMB 160,000,000 [5]. - The company is currently progressing with the investment projects as planned, but some funds are temporarily idle due to the construction cycle [5]. Cash Management Details - The company plans to use up to RMB 220,000,000 of temporarily idle raised funds and up to RMB 70,000,000 of its own funds for cash management within a 12-month period [6][10]. - The cash management will involve purchasing low-risk, highly liquid investment products with a maturity of no more than 12 months [6][7]. Implementation and Disclosure - The board of directors has authorized the management to make investment decisions and sign relevant legal documents for cash management [7]. - The company will disclose cash management details in accordance with regulatory requirements to ensure transparency [7]. Impact on Daily Operations - The cash management strategy is designed to not affect the normal operations or the progress of investment projects, ensuring that funds remain secure [8][10]. - The approach aims to improve fund efficiency and generate returns for the company and its shareholders [8]. Approval Process - The board and supervisory committee have approved the cash management proposal, confirming compliance with relevant regulations and the company's internal policies [9][11]. - The proposal is seen as beneficial for increasing fund utilization and investment returns without compromising the integrity of the raised funds [11].

Summary of Key Points Core Viewpoint - The company, Shanghai Aopumai Biotechnology Co., Ltd., plans to utilize part of its idle raised funds for cash management, with a maximum investment amount of RMB 700 million, ensuring high safety and liquidity in the investment products chosen [1][2][8]. Investment Overview - **Investment Purpose**: The aim is to maximize shareholder value by improving the efficiency of fund usage while ensuring that the use of raised funds is not affected and risks are effectively controlled [2][6]. - **Investment Amount and Duration**: The company intends to use up to RMB 700 million for cash management, with the funds being able to roll over within a 12-month period [2][5]. - **Source of Funds**: The funds are sourced from the proceeds of the company's initial public offering, which raised a total of approximately RMB 1.64 billion after deducting issuance costs [2][5]. Investment Methodology - The company will invest in high-safety, liquid financial products such as agreement deposits, structured deposits, time deposits, notice deposits, large certificates of deposit, and income certificates [1][5][6]. - The cash management products will not be used for pledging or for investment purposes in securities [5][6]. Approval Process - The board of directors and the supervisory board approved the cash management proposal during meetings held on August 21, 2025, with a validity period of 12 months from the date of approval [2][6][8]. - The management team has been authorized to make investment decisions and sign relevant contracts, with the finance department responsible for implementation [1][6]. Opinions from Supervisory Board and Sponsor - The supervisory board supports the cash management initiative, stating it will not affect the use of raised funds or harm the interests of the company and its shareholders [7][8]. - The sponsor, Guotai Junan Securities, has confirmed that the cash management plan complies with relevant regulations and will enhance fund usage efficiency without altering the intended use of raised funds [8].